Hudson Bay Capital Management
KRRO icon

Hudson Bay Capital Management’s Korro Bio KRRO Stock Holding History

Hudson Bay Capital Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-30,000
Closed -$1M – 1029
2024
Q3 		$1M Buy
+30,000
New +$1.26M ﹤0.01% 675

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hudson Bay Capital Management's KRRO Position: Q4 2024 in Review

Hudson Bay Capital Management sold out of Korro Bio (KRRO) in Q4 2024, closing a stake of 30,000 shares — an estimated $1M sold.

Hudson Bay Capital Management first reported a position in KRRO in Q3 2024 and held it in 1 quarter. The position peaked at $1M in Q3 2024. 84 funds tracked by Wall St. Rank hold KRRO as of Q4 2024.

  • Hudson Bay Capital Management reported no remaining Korro Bio position as of Q4 2024 after selling out during the quarter.
  • Hudson Bay Capital Management sold 30,000 Korro Bio shares in Q4 2024, an estimated $1M.
  • Hudson Bay Capital Management first reported a position in Korro Bio in Q3 2024 and held it in 1 quarter.
  • Hudson Bay Capital Management's Korro Bio position peaked at $1M in Q3 2024.
  • 84 funds tracked by Wall St. Rank held Korro Bio as of Q4 2024.

Based on Hudson Bay Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.